The FDA has approved IV ocrelizumab for treatment of relapsing-remitting MS in children and adolescents aged 10 years and ...

Glaucoma and hypertension were both linked with worsened cognitive performance, according to a poster presentation at the ...

The FDA has approved zenocutuzumab-zbco as the first drug for certain patients with a rare and aggressive bile duct cancer.

In the operating room, the “5-second rule” apparently does not apply.Researchers at Duke University Medical Center ...

Published results showed patients who received a higher number of corticosteroid injections before total shoulder ...

In this video, Monica Avila, MD, MPH, discusses results that showed letrozole alone was not noninferior to chemotherapy followed by letrozole for low-grade serous ovarian, fallopian tube or peritoneal ...

The National Kidney Foundation Spring Clinical Meetings opened with presentations on the latest innovations and wins in the ...

Myopia progressed more slowly across 2 years in children wearing Acuvue Abiliti 1-Day daily disposable contact lenses, ...

Mentoring from other patients may contribute to faster recovery time for patients undergoing hemodialysis, according to study ...

With several new therapies, extensive research and critical trials underway, nephrology is in a “golden age,” according to ...

Increasing influenza vaccination coverage to 70% could prevent more than 30,000 pediatric hospitalizations and 123 pediatric ...

Endocrine therapy is one of the top predictors of sexual dysfunction in women cancer survivors, according to a study shown at ...